Navigation Links
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Date:8/20/2007

at all, the risk that Soliris will not generate interest among physicians, the risk that estimates regarding the number of PNH patients are inaccurate, the risk that pending litigation may be resolved adversely, and a variety of other risks set forth from time to time in Alexion's filings with the Securities and Exchange Commission, including but not limited to the risks discussed in Alexion's Quarterly Report on Form 10-Q for the period ended June 30, 2007 and in our other filings with the Securities and Exchange Commission. Alexion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof, except when a duty arises under law.

(1) Rother R, Bell L, Hillmen P, Gladwin M. The clinical sequelae of

intravascular hemolysis and extracellular plasma hemoglobin. JAMA

2005; 293:1653-1662.

(2) Parker C, Omine M, Richards S, et al. Diagnosis and management of

paroxysmal nocturnal hemoglobinuria. Blood 2005; 106:3699-3709.

(3) Socie G, Mary J Yves, de Gramont A, et al. Paroxysmal nocturnal

haemoglobinuria: long-term follow-up and prognostic factors. Lancet

1996; 348:573-577.

(4) Hillmen P. Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history

of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;

333:1253-1258.

(5) Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of

paroxysmal nocturnal haemoglobinuria using modern diagnostic assays.

Br J Haematol. 2004;126:133-138.

(6) Araten DJ, Thaler HT, Luzzatto L. High incidence of thrombosis in

African-American and Latin-American patients with Paroxysmal

Nocturnal Haemoglobinuria. Thromb Haemost. 2005;93:88-91.

(7) Nishimura J, Kanakura Y, Ware RE et al. Clinical course and flow

cytometric analysis of paroxysmal nocturnal hemoglobinuria in the

United States and J
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
2. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
5. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015 RadiologyAuction will have their ... video and product demonstrations at the end of the ... such as Kodak and Fuji Cr,s, Agfa and Sony, ... the first event. Various imaging equipment will be available ... After years of buying and selling imaging ...
(Date:5/4/2015)... , May 4, 2015  Oncobiologics, Inc., a ... antibody (mAb) biosimilars, has completed the construction of ... headquarters in Cranbury, New Jersey ... facility is designed to utilize multiple technologies ... commercial scale.  Through the use of the latest ...
(Date:5/4/2015)... CARLSBAD, Calif. , May 4, 2015  Isis ... an exclusive license agreement with Bayer HealthCare (Bayer) to ... of thrombosis. Under the terms of the agreement, Isis ... near-term payments, including an immediate $100 million up-front payment ... program following a Phase 2 study in patients with ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
... , NEW YORK, Nov. 19 As ... is here. Here,s more on preparing yourself. , Listen to ... http://inr.mediaseed.tv/oneClip_C/?feed=ksLp_frMYEE7RzdnRfCsbxc9R2VXAOIF , Medialink is a division ... text, graphics and photos at http://www.thenewsmarket.com . ...
... , , NEWPORT NEWS, Va., Nov. 19 ... recognized and endorsed by two highly esteemed organizations for ... Imaging (SBI) and the American College of Surgeons. Both ... breakthrough imaging technology for the early detection of breast ...
Cached Medicine Technology:Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3
(Date:5/4/2015)... 04, 2015 Dr. Richard Champagne, DMD, ... chosen to receive the America’s Best Dentist Award, given ... selection as a top dentist is a reflection of ... education and his compassion for his patients. , Each ... exemplify excellence in their field. These nominees are dentists ...
(Date:5/4/2015)... Sylvia Hawthorn-Deppen shared her experiences living with ... others in similar situations that they were not alone, in ... Discovery of New Energy” (published by Balboa Press). This year ... renewed press campaign. , “I have spent nearly 60 years ... says. “As an adolescent I got into trouble with an ...
(Date:5/4/2015)... Vista, California (PRWEB) May 04, 2015 ... introduced a brand new lubricant -- Astroglide TTC™ ... impede sperm motility and alter pH levels, Astroglide TTC™ ... conception. , According to the Centers for Disease ... have trouble getting pregnant or sustaining a pregnancy, ...
(Date:5/4/2015)... 04, 2015 “ Food Cost Calculator ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... owners to manage and efficiently calculate food costs. , The ... In fact, the industry has an estimated 1.8 trillion dollar ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 ... just released the first-ever congenital heart disease ... Catheterization Laboratory (PCCL) accreditation. Driven by the ... are a comprehensive review of interventional procedures ... heart disease. , “The ACE CHD Standards ...
Breaking Medicine News(10 mins):Health News:New Jersey Dentist Dr. Richard Champagne Nominated for America’s Best Dentist Award 2Health News:Author launches new press campaign for 2012 book ‘Wheel’ 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 3Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Accreditation for Cardiovascular Excellence (ACE) Publishes New Standards for Pediatric and Adult Congenital Cardiac Catheterization Laboratories 2
... CLEVELAND, Feb. 4 Franklin & Seidelmann,( ... market penetration into the hospital sector with the,addition of ... , , -- Barnes-Kasson Hospital, Susquehanna, ... Owenton, KY, -- Syringa General Hospital, ...
... Kensey Nash Corporation (Nasdaq: KNSY ), a leading ... a wide range of medical procedures, today announced the resignation ... Ramius LLC, from its Board of Directors.Mr. Smith became a ... member of the Corporate Governance and Nominating Committee as well ...
... counterfeit and adulterated medicines posing an increasing risk to ... Pharmacopeial (USP) Convention today announces new standards for two ... episodes of adulteration resulting in patient deaths. , ... heparin and the sweetener glycerin, comes on the heels ...
... Impacts One in Four Americans Show Features Real People with ... Bob Schieffer and Denver Broncos, Quarterback Jay CutlerWESTPORT, Conn., Feb. ... today the new 2009 television schedule for dLifeTV ... people living with diabetes, airing every Sunday on CNBC at ...
... U.S. Preventive Medicine(R), the leader in disease prevention ... Christopher Fey, Chairman and CEO, and Fred Goldstein, President ... Services Conference, to be held February 9-11 in New ... U.S. Preventive Medicine will participate in this exclusive conference ...
... and special product offerings available in store during ... CVS/pharmacy, America,s largest retail pharmacy, will mark American ... about maintaining heart health and preventing heart disease. ... month on many heart health-related products.Heart disease is ...
Cached Medicine News:Health News:Franklin & Seidelmann Expands into Critical Access Hospital Market Provides 24 x 7 Teleradiology Service for Three New Clients 2Health News:Franklin & Seidelmann Expands into Critical Access Hospital Market Provides 24 x 7 Teleradiology Service for Three New Clients 3Health News:Kensey Nash Announces Director Resignation 2Health News:USP announces new standards to protect patients from counterfeit and adulterated medicines 2Health News:dLifeTV Announces New Season Programming and Celebrity Guests; Only Nationally-Broadcast Program About Diabetes Celebrates 5th Year and 200th Show 2Health News:dLifeTV Announces New Season Programming and Celebrity Guests; Only Nationally-Broadcast Program About Diabetes Celebrates 5th Year and 200th Show 3Health News:U.S. Preventive Medicine(R) Executives to Present at 2009 UBS Global Healthcare Services Conference 2Health News:CVS/pharmacy Taking Health to Heart in February 2Health News:CVS/pharmacy Taking Health to Heart in February 3
The New Vantage Plus. The PLUS gives you: ,P Premium intelligent optics ,L Lighter weight and brighter images ,U Unique wireless patented technology ,S Smaller and more compact size ...
STAT-CRIT is a rapid, one-step system for measuring hematocrit....
... Simple, compact, and easy to use, ... surgery technology to every OR. The business ... provide hospitals and surgeons with the most ... their facilities. ,The z-boxTM is designed to ...
...
Medicine Products: